GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Mon, 22 Apr 2024

ANTH Predictions History

2 years ago
dimyto.284299 predicted that ANTH for 2022-01-11 is going

Rank:

4 years ago
NameNotImportant predicted that ANTH for 2019-05-06 is going $0.0880 (4.36%)

4 years ago
NameNotImportant predicted that ANTH for 2019-05-03 is going $0.0810 (1.25%)

6 years ago
marcos predicted that ANTH for 2018-04-16 is going $0.350 (0.03%)

Rank:

6 years ago
marcos predicted that ANTH for 2018-04-11 is going $0.350 (1.77%)

Rank:

6 years ago
Marcos.Lopez.23288 predicted that ANTH for 2018-04-05 is going $0.340 (5.04%)

Rank:

6 years ago
JS predicted that ANTH for 2018-03-20 is going $0.370 (12.43%)

6 years ago
Jessie.Williams.22237 predicted that ANTH for 2018-03-20 is going $0.400 (21.54%)

Rank:

6 years ago
Sunny.Chyun.21972 predicted that ANTH for 2018-03-20 is going $0.366 (1.67%)

Rank:

6 years ago
JS predicted that ANTH for 2018-03-14 is going $0.559 (22.16%)

Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT